Two newly identified disease-causing genes, known as Bzw2 and Eif5a2, have been implicated in early prostate cancer ...

Separate studies investigated the potential role of multiparametric MRI in refining prostate cancer active surveillance practices, such as confirmatory biopsy.

Keck Medicine of USC is conducting a clinical trial that explores using steam as a potential alternative to surgery or ...

Prostate cancer remains one of the most prevalent cancers among men worldwide. For patients with advanced or metastatic ...

A diet high in omega-3 fatty acids and low in omega-6 fatty acids, taken with fish oil, reduced the Ki-67 index in men with prostate cancer on active surveillance.

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

ROACH: I am a 66-year-old white male who is active and relatively healthy. I have recently been diagnosed with prostate cancer. One blood test showed a PSA level of 13 ng/mL, and a second was 17 ng/mL ...

Key Strategies Against Drug-Resistant Prostate Cancer Nov. 20, 2024 — An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers ...

The PEACE-1 trial (NCT01957436) revealed that adding radiotherapy to standard of care (SOC) and abiraterone significantly ...

On track to report updated overall survival data for CAN-2409 from phase 2a clinical trials in pancreatic ductal adenocarcinoma (PDAC) and ...

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) has been given a consensus rating of “Buy” by the thirteen ratings firms that are presently covering the firm, MarketBeat reports. One research ...

ImmunityBio, Inc.'s Anktiva shows promise for solid tumors, with growing sales and financing boosting growth potential. Click ...